FLY26 is a selective partial antagonist of GluN2B, with an IC50 value of 0.64 µM. FLY26 inhibits the GluN2B subunit of NMDA receptors, reducing calcium ion influx and reactive oxygen species (ROS) production. It also activates the BDNF/TrkB/CREB neuroprotective signaling pathway, mitigating excitotoxicity and mitochondrial dysfunction. FLY26 holds potential for treating neurological deficits caused by cerebral ischemia-reperfusion injury.
Formula:
C22H23N5O3
Target:
Reactive Oxygen Species|||Trk receptor|||iGluR
* VAT and and shipping costs not included. Errors and price changes excepted
